These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1105 related items for PubMed ID: 25467043

  • 1. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P, Dilgil M, Gudi A, Shah A, Akwaa C, Homburg R.
    Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
    [Abstract] [Full Text] [Related]

  • 2. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ, Stojanović N, Duhamel A, Dewailly D.
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [Abstract] [Full Text] [Related]

  • 3. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P, Kulkarni A, Dilgil M, Dhir P, Shah A, Gudi A, Homburg R.
    Gynecol Endocrinol; 2017 Oct 01; 33(10):801-806. PubMed ID: 28454499
    [Abstract] [Full Text] [Related]

  • 5. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H, Hellström M, Gull B, Lind AK, Nilsson L, Janson PO, Stener-Victorin E.
    Fertil Steril; 2014 Jun 01; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [Abstract] [Full Text] [Related]

  • 6. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
    Eilertsen TB, Vanky E, Carlsen SM.
    Hum Reprod; 2012 Aug 01; 27(8):2494-502. PubMed ID: 22693172
    [Abstract] [Full Text] [Related]

  • 7. Revised criteria for PCOS in WHO Group II anovulatory infertility - a revival of hypothalamic amenorrhoea?
    Lauritsen MP, Pinborg A, Loft A, Petersen JH, Mikkelsen AL, Bjerge MR, Nyboe Andersen A.
    Clin Endocrinol (Oxf); 2015 Apr 01; 82(4):584-91. PubMed ID: 25262871
    [Abstract] [Full Text] [Related]

  • 8. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D, Alebić MŠ, Duhamel A, Stojanović N.
    Hum Reprod; 2014 Nov 01; 29(11):2536-43. PubMed ID: 25267785
    [Abstract] [Full Text] [Related]

  • 9. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
    Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, Escobar-Morreale HF.
    Hum Reprod Update; 2014 Nov 01; 20(3):334-52. PubMed ID: 24345633
    [Abstract] [Full Text] [Related]

  • 10. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.
    Hum Reprod; 2014 Apr 01; 29(4):791-801. PubMed ID: 24435776
    [Abstract] [Full Text] [Related]

  • 11. Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome.
    Cui Y, Shi Y, Cui L, Han T, Gao X, Chen ZJ.
    Fertil Steril; 2014 Jul 01; 102(1):230-236.e2. PubMed ID: 24746743
    [Abstract] [Full Text] [Related]

  • 12. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1716-1722. PubMed ID: 28854589
    [Abstract] [Full Text] [Related]

  • 13. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Aug 01; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 14. Anti-Müllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population.
    Bozdag G, Mumusoglu S, Coskun ZY, Yarali H, Yildiz BO.
    Reprod Biomed Online; 2019 Sep 01; 39(3):522-529. PubMed ID: 31182353
    [Abstract] [Full Text] [Related]

  • 15. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
    Homburg R, Ray A, Bhide P, Gudi A, Shah A, Timms P, Grayson K.
    Hum Reprod; 2013 Apr 01; 28(4):1077-83. PubMed ID: 23377771
    [Abstract] [Full Text] [Related]

  • 16. Antimüllerian hormone to determine polycystic ovarian morphology.
    Dietz de Loos A, Hund M, Buck K, Meun C, Sillman J, Laven JSE.
    Fertil Steril; 2021 Oct 01; 116(4):1149-1157. PubMed ID: 34579824
    [Abstract] [Full Text] [Related]

  • 17. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.
    Sahmay S, Atakul N, Oncul M, Tuten A, Aydogan B, Seyisoglu H.
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep 01; 170(1):157-61. PubMed ID: 23806449
    [Abstract] [Full Text] [Related]

  • 18. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
    Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I.
    Hum Reprod; 2009 Nov 01; 24(11):2917-23. PubMed ID: 19617605
    [Abstract] [Full Text] [Related]

  • 19. Differential rate in decline in ovarian reserve markers in women with polycystic ovary syndrome compared with control subjects: results of a longitudinal study.
    Ahmad AK, Kao CN, Quinn M, Lenhart N, Rosen M, Cedars MI, Huddleston H.
    Fertil Steril; 2018 Mar 01; 109(3):526-531. PubMed ID: 29428308
    [Abstract] [Full Text] [Related]

  • 20. Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.
    El-Mazny A, Abou-Salem N.
    Gynecol Endocrinol; 2013 Sep 01; 29(9):826-9. PubMed ID: 23855354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.